Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC38182 Dauricine

    蝙蝠葛碱

    Dauricine是一种从Menispermum dauricum DC.中提取的具有抗癌活性的生物碱。
  3. GC38181 Eriocitrin

    圣草次甙

    A flavonoid with antioxidant activity
  4. GC38179 Didymin

    香风草甙

    A flavonoid with diverse biological activities
  5. GC38165 Euphorbia Factor L1

    大戟因子L1

    Euphorbia factor L1, a diterpenoid isolated from Euphorbia lathyris, inhibits osteoclastogenesis and induces osteoclast apoptosis.
  6. GC38160 Demethylzeylasteral

    去甲泽拉木醛

    Demethylzeylasteral是从传统中药雷公藤中提取的三萜类化合物。
  7. GC38149 Ecabet sodium

    依卡倍特钠,TA-2711

    An antiulcerative and gastroprotective agent
  8. GC38131 BMS-1166 hydrochloride A PD-1/PD-L1 interaction inhibitor
  9. GC38099 Higenamine

    去甲乌药碱; Norcoclaurine

    Demethyl-Coclaurine (Higenamine, Norcoclaurine), the key component of the Chinese herb aconite root, is a beta-2 adrenergic receptor (β2-AR) agonist. Demethyl-Coclaurine stimulates AKT phosphorylation and requires PI3K activation for the anti-apoptotic effect in cardiomyocytes.
  10. GC38088 Hederacolchiside A1

    革叶常春藤皂苷 A1

    Hederacolchiside A1 是从白头翁中分离的,通过调节 PI3K/Akt/mTOR 信号通路诱导凋亡,从而抑制肿瘤细胞的增殖。Hederacolchiside A1 具有抗血吸虫病活性,影响体内和体外的寄生虫生存力。
  11. GC38086 Linderalactone

    异乌药内酯

    Linderalactone inhibits human lung cancer growth by modulating the expression of apoptosis-related proteins (Bax and Bcl-2) with an IC50 of 15 ?M in A-549 cells. Linderalactone induces G2/M cell cycle arrest and could also suppress the JAK/STAT signalling pathway. Linderalactone can be isolated from Radix linderae.
  12. GC38083 Ethoxysanguinarine

    乙氧基血根碱

    Ethoxysanguinarine 是主要存在龙葵中的一种 benzophenanthridine 生物碱天然产物。Ethoxysanguinarine 通过抑制蛋白磷酸酶 2A (CIP2A),抑制结直肠癌细胞的活力,诱导细胞凋亡。
  13. GC38060 Shield-1

    Shld1

    Shield-1是一种特异性、细胞可渗透的FK506结合蛋白-12 (FKBP)配体。
  14. GC38044 Fraxinellone

    梣酮

    A liminoid degradant with diverse biological activities
  15. GC38037 GSK2983559 free acid A RIPK2 inhibitor
  16. GC38014 BT2

    3,6-二氯-2-苯并噻吩羧酸

    An Mcl-1 inhibitor
  17. GA23337 Oxythiamine . HCl

    羟基硫胺盐酸盐

    A thiamine antimetabolite
  18. GA21397 Dolastatin 15

    DLS 15

    A peptide with anticancer activity
  19. GA20897 Boc-Arg(Boc)₂-OH

    三叔丁氧羰基精氨酸

    An amino acid building block
  20. GA20494 Ac-Asp-Glu-Val-Asp-pNA

    Ac-Asp-Glu-Val-Asp-pNA

    A colorimetric caspase substrate
  21. GA20156 (D-Ser(tBu)⁶,Azagly¹⁰)-LHRH (free base)

    戈舍瑞林; ICI 118630

  22. GC45554 Questiomycin A A phenoxazine and chromophore with antibacterial and anticancer activities
  23. GC45550 Pogostone

    广藿香酮

    Pogostone是一种吡喃酮,是Pogostemonis Herba的精油制剂的主要成分。
  24. GC45549 Pitstop2 Pitstop2是一种网格蛋白抑制剂,可抑制网格蛋白末端结构域的两性结合,IC50值为12μM。
  25. GC45538 Oxychlororaphine

    吩嗪-1-甲酰胺,phenazine-1-carboxamide

    A microbial metabolite with diverse biological activities
  26. GC45536 Oleic Acid-13C

    油酸-1-13C,9-cis-Octadecenoic acid-13C; 9Z-Octadecenoic acid-13C

    An internal standard for the quantification of oleic acid
  27. GC45523 Nemorosone A PPAP with antiproliferative properties
  28. GC45515 MX1013

    CV1013; Z-VD-FMK

    A dipeptide pan-caspase inhibitor
  29. GC45473 Histone H2BK12ac (1-22)-GGK-biotin amide (trifluoroacetate salt)
  30. GC45467 Harzianum A A trichothecene fungal metabolite
  31. GC45414 CRT0066854 A PKCι and PKCζ inhibitor
  32. GC45385 Ara-G

    9-Β-D-糖呋喃鸟嘌呤

    An anticancer nucleoside analog
  33. GC45354 4β-Hydroxywithanolide E

    4BETA-羟基醉茄内酯E

    A withanolide with anti-inflammatory and anticancer activities
  34. GC45353 4-oxo-27-TBDMS Withaferin A A derivative of withaferin A with anticancer activity
  35. GC45352 4-oxo Withaferin A

    4-oxo Withaferin A

    A derivative of withaferin A with anticancer activity
  36. GC45324 2,5-dimethyl Celecoxib

    2,5-二甲基塞来考昔

    An anticancer celecoxib derivative
  37. GC45277 (±)-Camphene

    DL-Camphene, NSC 4165

     
  38. GC45274 (+)-Pinoresinol

    松脂素,(+)-Pinoresinol

    A lignan with diverse biological activities
  39. GC37974 ZYZ-488 ZYZ-488 是一种竞争性凋亡蛋白酶激活因子-1 (Apaf-1) 抑制剂,抑制结合蛋白 procaspase-9 和 procaspase-3 的激活。
  40. GC37964 Zeylenone

    山椒子烯酮

    Zeylenone,可从 Uvaria grandiflora Roxb 的叶子的乙醇萃取物分离。Zeylenone 是一种天然存在的环己烯氧化物,通过 PI3K/AKT/mTOR 和 MAPK/ERK 信号通路抑制宫颈癌细胞增殖并诱导细胞凋亡 (apoptosis)。
  41. GC37900 Verubulin

    (4-甲氧基苯基)(甲基)(2-甲基喹唑啉-4-基)胺,MPC 6827

    Verubulin hydrochloride(MPC 6827 hydrochloride) is a microtubule destabilizer and vascular disrupting agent that achieve high brain concentration relative to plasma in animals.
  42. GC37887 Vanillyl alcohol

    香草醇,p-(Hydroxymethyl)guaiacol

    Vanillyl alcohol (4-Hydroxy-3-methoxybenzyl alcohol, Vanillin alcohol, Vanillic alcohol, 3-Methoxy-4-hydroxybenzyl alcohol), derived from vanillin, is used to flavor food.
  43. GC37873 Ursonic acid

    熊果酮酸; 3-Ketoursolic acid

    Ursonic acid (Prunol, Malol, beta-Ursolic acid, NSC4060, CCRIS 7123, TOS-BB-0966), present in many plants, is a pentacyclic triterpenoid that can be used as a cosmetics additive and serve as a starting material for synthesis of more potent bioactive derivatives, such as experimental antitumor agents. Ursonic acid induces the apoptosis of human cancer cells through multiple signaling pathways.
  44. GC37844 Tubulysin M

    微管蛋白抑制剂 M

    Tubulysin M 是一种高度细胞毒性的肽,是从粘细菌 Archangium geophyra 和 Angiococcus disciformis 中分离的。 Tubulysin 在哺乳动物细胞中显示出极其有效的细胞毒活性,包括多药耐药细胞系,IC50 值在较低的纳摩尔范围内。 Tubulysin M 是一种具有细胞毒性活性微管溶素,抑制微管蛋白聚合并导致细胞周期停滞和凋亡。
  45. GC37843 Tubulysin I

    微管蛋白抑制剂 I

    Tubulysin I 是一种高度细胞毒性的肽,是从粘细菌 Archangium geophyra 和 Angiococcus disciformis 中分离的。 Tubulysin 在哺乳动物细胞中显示出极其有效的细胞毒活性,包括多药耐药细胞系,IC50 值在较低的纳摩尔范围内。 Tubulysin I 是一种具有细胞毒性活性微管溶素,抑制微管蛋白聚合并导致细胞周期停滞和凋亡。
  46. GC37842 Tubulysin H

    微管蛋白抑制剂 H

    Tubulysin H 是一种高度细胞毒性的肽,是从粘细菌 Archangium geophyra 和 Angiococcus disciformis 中分离的。 Tubulysin 在哺乳动物细胞中显示出极其有效的细胞毒活性,包括多药耐药细胞系,IC50 值在较低的纳摩尔范围内。 Tubulysin H 是一种具有细胞毒性活性微管溶素,抑制微管蛋白聚合并导致细胞周期停滞和凋亡。
  47. GC37841 Tubulysin G

    微管蛋白抑制剂 G

    Tubulysin G 是一种高度细胞毒性的肽,是从粘细菌 Archangium geophyra 和 Angiococcus disciformis 中分离的。 Tubulysin 在哺乳动物细胞中显示出极其有效的细胞毒活性,包括多药耐药细胞系,IC50 值在较低的纳摩尔范围内。 Tubulysin G 是一种具有细胞毒性活性微管溶素,抑制微管蛋白聚合并导致细胞周期停滞和凋亡。
  48. GC37840 Tubulysin F

    微管蛋白抑制剂 F

    Tubulysin F 是一种高度细胞毒性的肽,是从粘细菌 Archangium geophyra 和 Angiococcus disciformis 中分离的。 Tubulysin 在哺乳动物细胞中显示出极其有效的细胞毒活性,包括多药耐药细胞系,IC50 值在较低的纳摩尔范围内。 Tubulysin F 是一种具有细胞毒性活性微管溶素,抑制微管蛋白聚合并导致细胞周期停滞和凋亡。
  49. GC37839 Tubulysin E

    微管蛋白抑制剂 E

    Tubulysin E 是一种高度细胞毒性的肽,是从粘细菌 Archangium geophyra 和 Angiococcus disciformis 中分离的。 Tubulysin 在哺乳动物细胞中显示出极其有效的细胞毒活性,包括多药耐药细胞系,IC50 值在较低的纳摩尔范围内。 Tubulysin E 是一种具有细胞毒性活性微管溶素,抑制微管蛋白聚合并导致细胞周期停滞和凋亡。
  50. GC37837 Tubulysin C

    微管蛋白抑制剂 C

    Tubulysin C 是一种高度细胞毒性的肽,是从粘细菌 Archangium geophyra 和 Angiococcus disciformis 中分离的。 Tubulysin 在哺乳动物细胞中显示出极其有效的细胞毒活性,包括多药耐药细胞系,IC50 值在较低的纳摩尔范围内。 Tubulysin C 是一种具有细胞毒性活性微管溶素,抑制微管蛋白聚合并导致细胞周期停滞和凋亡。
  51. GC37836 Tubulysin B Tubulysin B 是一种高度细胞毒性的肽,有效的微管去稳定剂,是从粘细菌 Archangium geophyra 和 Angiococcus disciformis 中分离的。Tubulysin B 抑制许多癌细胞系,包括具有多药抗性的细胞系,IC50 值在皮纳摩尔范围内。Tubulysin B 是一种具有细胞毒性活性微管溶素,抑制微管蛋白聚合并导致细胞周期停滞和凋亡。

Items 1201 to 1250 of 2721 total

per page

Set Descending Direction